As MYC(N) is a key driver of tumorigenesis not only in neuroblastoma, combination the conditional LSL-MYCN mouse with other cre-transgenic models bear the potential to also model tumorigenesis of other human malignancies. Here, MYC is linked to neuroblastoma.